Dr Laura McCoullough is an early-career researcher in the Revill/Littlejohn Lab at the Doherty Institute. Laura completed her PhD studies at the Doherty Institute, researching a novel treatment for chronic hepatitis B infection using CRISPR-Cas13b. She has continued on these studies during her postdoc.
